Hims & Hers Stock Pops 40%: Everything You Need to Know

MrDecoder · 2026-03-09T20:51:50+00:00

Novo Nordisk dropped its lawsuit against Hims & Hers and announced a partnership, allowing Hims & Hers to offer branded products at lower prices. This led to a 40% surge in Hims & Hers stock, signaling potential future growth.

MrDecoder

2026-03-09 20:51:50

Abstract generation in progress

Earlier this year, Novo Nordisk (NVO +2.79%) sued Hims & Hers (HIMS +37.42%), which investors thought was the end of the telehealth company.

Today, Novo not only dropped their lawsuit, they announced a partnership with Hims & Hers that will bring its branded products to the platform at a low price. Shares of Hims & Hers responded by jumping 40% and this may only be the start of the pop in shares as peptides and other treatments come to the Hims & Hers platform.

*Stock prices used were end-of-day prices of March 9, 2026. The video was published on March 9, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes